Form D · Biotechnology
Neurotrope, Inc.
New York, NY · CIK 0001513856
Offering snapshot reported Dec 1, 2016 · SEC filing
- Reported sold
- $24.5M Offering amount: $24.5M
- Investors reported
- 221 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 17, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 1, 2016 | Initial | $24,505,975 | No comparison | 221 | SEC filing |
| Nov 24, 2015 | Initial | $15,329,920 | No comparison | 136 | SEC filing |
| Oct 21, 2013 | Initial | $1,080,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.45M
- Finders' fees
- $0
- Form D file number
- 021-275463
The two placement agents also received warrants to purchase stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Katalyst Securities LLC | 112494 | |
| GP Nurmenkari Inc. | 153480 |
Source: Form D, filed Dec 1, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Abeles | Director |
| Dan Alkon | Executive |
| Larry D. Altstiel, Md | Director |
| Ralph Bean | Director |
| Bruce Bernstein | Director |
| Paul E. Freiman | Director |
| Kenneth Gorelick | Director |
| James Gottlieb | Director |
| Jay M. Haft | Director |
| James New | Director, Executive |
| Shana Phares | Director |
| Charles S. Ramat | Director, Executive |
| Joshua Silverman | Director |
| William Singer | Director |
| Robert Weinstein | Executive |
| Susanne Wilke | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
205 East 42 Nd Street, 16 Th Floor
New York, NY, 10017
New York, NY, 10017